INHIBRX INBX 深 沪
等待开盘 10-10 09:30:00 美东时间
35.00
+1.390
+4.14%
华盛通- 最 高35.96
- 今 开33.52
- 成交量 36.37万股
- 最 低 33.095
- 昨 收 33.61
- 总市值 5.07亿
- 52周最高 37.5307
- 市盈率 静 0.30
- 换手率 2.51%
- 52周最低 10.805
- 委 比 -84.49%
- 总股本 1448.54万
- 历史最高 50.97
- 量 比 3.51
- 振 幅 8.52%
- 历史最低 7.67
- 每 手 1
- 风险率 9.93%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多JMP Securities Reiterates Market Perform on Inhibrx Biosciencesto Market Perform
JMP Securities analyst Reni J. Benjamin reiterates Inhibrx Biosciences (NASDAQ:INBX) from Market Perform to Market Perform.
08-22 20:55
读懂IPO|科望医药6条研发管线尚未商业化，企业称账面资金可支撑后续研发
本文来源：时代商业研究院 作者：彭元重 来源|时代商业研究院 作者|彭元重 凭借着“18A”制度的政策支持，今年以来，已有12家未盈利的生物医药企业成...
07-29 22:15
Incannex Healthcare Cancels All Outstanding Series A Warrants Following Strategic ATM Execution
Incannex Healthcare successfully canceled all remaining Series A Warrants, eliminating potential dilution and streamlining its capital structure. This move clears the way for upcoming Phase 2 clinical milestones, including the topline data from the RePOSA trial of IHL-42X for obstructive sleep apnea, expected in July 2025. The company highlights its commitment to disciplined capital management and long-term value creation for shareholders.
06-12 11:30
95亿美元！赛诺菲收购罕见病疗法公司
（转自：求实药社） 6月2日，法国制药巨头赛诺菲与美国生物药企Blueprint Medicines公司宣布达成收购协议，赛诺菲将以约95亿美元的潜在总金额收购...
06-04 11:58
科望医药-B，递交IPO招股书，拟赴香港上市，中信证券独家保荐
炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 2025年5月23日，来自江苏苏州的科望医药集团Elpis...
05-24 14:08
Inhibrx Biosciences shares are trading higher after the company reported better-than-expected Q1 EPS results.
Inhibrx Biosciences shares are trading higher after the company reported better...
05-15 23:47
JMP Securities Reiterates Market Perform on Inhibrx Biosciencesto Market Perform
JMP Securities analyst Reni Benjamin reiterates Inhibrx Biosciences (NASDAQ:INBX) from Market Perform to Market Perform.
05-15 22:02
Inhibrx Q1 EPS $(2.80) Beats $(2.84) Estimate
Inhibrx (NASDAQ:INBX) reported quarterly losses of $(2.80) per share which beat the analyst consensus estimate of $(2.84) by 1.41 percent. This is a 51.47 percent increase over losses of $(5.77) per share from the same
05-15 04:25
